Quantamental Technologies’s Audentes Therapeutics, Inc BOLD Stock Holding History

Quantamental Technologies’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,213	Closed	-$372K	–	467
2019 Q4	$372K	Buy	6,213 +2,813	+83%	+$106K	0.19%	191
2019 Q3	$96K	Buy	3,400 +3,245	+2,094%	+$111K	0.03%	754
2019 Q2	$6K	Buy	+155	New	+$5.96K	﹤0.01%	1323

Quantamental Technologies's BOLD Position: Q1 2020 in Review

Quantamental Technologies sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 6,213 shares — an estimated $372K sold.

Quantamental Technologies first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $372K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Quantamental Technologies reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Quantamental Technologies sold 6,213 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $372K.
Quantamental Technologies first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
Quantamental Technologies's Audentes Therapeutics, Inc position peaked at $372K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Quantamental Technologies's 13F filing for Q1 2020, filed 15 May 2020.